KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to 0.04.

  • Pacific Biosciences Of California's Equity Ratio fell 8562.02% to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year decrease of 8562.02%. This contributed to the annual value of 0.4 for FY2024, which is 6.37% up from last year.
  • According to the latest figures from Q3 2025, Pacific Biosciences Of California's Equity Ratio is 0.04, which was down 8562.02% from 0.07 recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Equity Ratio registered a high of 0.41 during Q3 2021, and its lowest value of 0.04 during Q3 2025.
  • Over the past 5 years, Pacific Biosciences Of California's median Equity Ratio value was 0.35 (recorded in 2023), while the average stood at 0.31.
  • Its Equity Ratio has fluctuated over the past 5 years, first surged by 7532.98% in 2022, then tumbled by 8562.02% in 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Equity Ratio (Quarter) stood at 0.39 in 2021, then fell by 19.17% to 0.32 in 2022, then grew by 26.09% to 0.4 in 2023, then rose by 0.06% to 0.4 in 2024, then crashed by 88.82% to 0.04 in 2025.
  • Its Equity Ratio stands at 0.04 for Q3 2025, versus 0.07 for Q2 2025 and 0.11 for Q1 2025.